What Are the Best Supplement Options for Women Dealing With Second-Puberty-Style Weight Gain?

If you've started using "second puberty" to describe what your body is doing in your late thirties, forties, or early fifties, you are not being dramatic. The term has become shorthand for a real and well-documented experience: the hormonal cascade of perimenopause, which often arrives years before the final menstrual period and reshapes body composition in ways the scale alone fails to capture. Fat redistributes toward the abdomen. Lean muscle quietly leaves. The same diet that worked at thirty stops working. That experience has biological fingerprints, and the honest answer to "what supplement fixes this" is more complicated than supplement marketing suggests.

This article covers what is actually happening in second puberty, what the supplement evidence does and does not say, and the interventions that have the strongest evidence for body composition in this life stage.

The Gist

The strongest evidence-based interventions for second-puberty weight gain are not supplements. Resistance training, aerobic exercise, sleep, protein adequacy, and clinical evaluation including a hormone therapy discussion with your clinician sit at the top of the list.

Supplement evidence specific to perimenopausal weight gain is thinner than the marketing suggests. A small set of probiotic strains have human RCT data on body composition endpoints in mixed-sex overweight or obese adult populations. None of those trials were stratified by menopausal status. Read product claims with that gap in mind.

WONDERBIOTICS Probiotics for Weight Management is a general weight-management formula, not a perimenopause product. Its strain-level evidence comes from mixed-sex adult populations, and its relevance to women in second puberty rests on that general data rather than menopause-specific trials.

What "Second Puberty" Actually Is

The term women use captures something the medical literature has documented in detail. The Study of Women's Health Across the Nation (SWAN), an 18-year longitudinal cohort, found that approximately 2 years before the final menstrual period (FMP), the rate of fat gain doubles and lean body mass starts to decline. Fat gains and lean losses continue until about 2 years after the FMP, after which the trajectories flatten. Strikingly, total body weight climbs linearly throughout the premenopausal years without accelerating at the menopausal transition itself. The shift is in body composition, not necessarily in the number on the scale.[1]

That finding matters because it explains a common frustration. A woman in second puberty may report: "My weight is the same, but nothing fits." She is not imagining it. She is observing the trade-off SWAN measured: more fat, less muscle, redistributed toward the abdomen, often without an accelerated change in total weight. The metric that captures this shift is body composition (fat mass percentage, lean mass, waist circumference), not weight alone.

Underlying biology includes declining estradiol, shifting insulin sensitivity, sleep disruption from hot flashes, and downstream changes in resting energy expenditure and appetite regulation. The full mechanism is beyond the scope of this article, while the operational implication is straightforward: tools that move body composition (lean mass, fat mass, waist) are more relevant in this stage than tools that only target the scale.

Terms to Know!

• Perimenopause: the transition phase before the final menstrual period during which hormonal fluctuations begin and body composition typically starts to shift; it can last 4 or more years and often begins in a woman's mid-40s, though timing varies.
• Visceral adiposity: fat stored deep in the abdominal cavity around internal organs, distinct from subcutaneous fat under the skin; visceral fat is more strongly associated with cardiometabolic risk and tends to increase during the menopause transition even when total weight is stable.

What the Supplement Evidence Actually Says

Supplement marketing aimed at women in this life stage often implies a product is "for perimenopause" or "for menopause weight gain." Read those claims carefully. Most supplements marketed this way do not have RCT data stratified by menopausal status.

The probiotic literature is illustrative. Probiotic effects depend on the specific strain, and evidence from one strain does not transfer to another.[2] A small set of named strains (B420, LG2055, CGMCC 1.3724) have published human RCTs on weight-related endpoints (body fat mass, waist circumference, energy intake, weight loss). These trials enrolled overweight or obese adult populations of mixed or single sex, none with menopausal-status stratification as a primary or pre-specified secondary analysis. The strain-level evidence applies to the trial populations as enrolled. It does not constitute a direct demonstration in perimenopausal women specifically.

Other supplement categories often marketed to perimenopausal women face their own evidence questions. Phytoestrogens (soy isoflavones) have published data primarily on vasomotor symptoms (hot flashes, night sweats), with body-composition data more limited. Black cohosh has mixed evidence for hot flashes and is not a body-composition intervention. Calcium and vitamin D are well-established for bone health in this life stage, with body-composition effects beyond bone mineral density not their primary indication.

The honest summary: no supplement has strong, replicated RCT evidence for treating perimenopausal weight gain specifically. Some supplements have evidence on body-composition endpoints in adjacent populations and may be reasonable adjuncts. None replace the interventions with the most consistent evidence base.

What Does Have Evidence: Beyond Supplements

The interventions with the strongest published evidence for body composition during and after the menopause transition are not supplements.

Resistance training plus aerobic exercise. A 2023 systematic review and meta-analysis of exercise training in postmenopausal women found that exercise improved body composition overall. Aerobic training was effective for fat loss, resistance training was effective for muscle gain, and the combination of both has been considered a viable strategy for this population.[3] The lean-mass loss SWAN documented is not inevitable. It responds to load. A targeted resistance training program (compound lifts, progressive overload, twice or three times weekly) is the closest thing this literature has to a non-pharmacological gold standard for body composition in this life stage.

Protein adequacy. Higher dietary protein supports lean mass retention during weight loss and is particularly relevant when sarcopenia (age-related muscle loss) intersects with menopausal lean-mass decline. Discuss specific intake targets with a registered dietitian who can account for your kidney function and total energy needs.

Sleep regularization. Sleep disruption from vasomotor symptoms cascades into appetite hormone shifts and reduced training capacity. Treating the sleep problem (clinically when warranted, including evaluation for sleep apnea) often does more for body composition than any supplement.

Clinical evaluation. Second puberty is the right moment to talk with a clinician about thyroid function (often relevant in midlife women), iron status, glucose regulation, and whether menopausal hormone therapy (MHT, sometimes called HRT) is appropriate for you. The MHT decision involves benefits, risks, and timing considerations that vary by individual and require a clinical conversation. Supplements are not a substitute for this evaluation.

A reasonable framework: build the foundation (training, sleep, protein, clinical evaluation), then consider whether a supplement adds something specific on top. Do not invert the order.

How to Read a Probiotic Label in This Context

If you are considering a probiotic alongside the foundation above, the same evaluation criteria apply that apply to any probiotic decision.

Named strains with full identifiers. Genus, species, and strain code (such as B420™ or HN019). Anonymous lactobacillus blends cannot be matched to specific human evidence.

Evidence on relevant endpoints. Look for human RCT data on body composition outcomes (body fat mass, waist circumference) rather than only on digestive comfort. The endpoint a strain has been studied for is the endpoint its evidence applies to.

Honest population framing. Most probiotic weight-management trials enrolled mixed-sex overweight or obese adult populations. A product claiming menopause-specific benefits, without citing a menopause-specific trial, is overstating its evidence base. A product describing strain-level data in mixed-sex adults, without that overstatement, is being more honest.

Delivery technology. Live strains have to survive shelf life and digestion. Specific testable claims (acid survival, viability through to the point of consumption) carry more weight than the phrase "live cultures" alone.

How WONDERBIOTICS Fits Into This Picture

WONDERBIOTICS Probiotics for Weight Management is a general weight-management formula. It is not marketed as a perimenopause or menopause product, and the strain-level evidence behind it does not include menopausal-status-stratified trial data.

• B420™ is the probiotic strain in the formula. A 6-month randomized, placebo-controlled trial enrolled 225 overweight and obese adults aged 18-65, with post-hoc factorial analysis showing body fat mass differed by -4.0% versus placebo (P=0.002), waist circumference dropped by 2.4 cm more than placebo, and daily energy intake was reduced by approximately 300 kcal compared to placebo.[4] The trial enrolled both sexes and did not stratify by menopausal status. The relevance to women in second puberty rests on the general body-composition signal in the trial population, not on a perimenopause-specific demonstration.
• Eriomin® (lemon extract) is a citrus flavonoid extract studied for its effects on appetite-related signaling. Ingredient-level clinical research in prediabetic adults reports support for natural GLP-1 levels and adiponectin levels.[5] The cited research enrolled prediabetic adults of both sexes. It was not menopause-specific.
• Dihydroberberine is a modified version of berberine that achieves higher plasma berberine exposure at lower doses. It supports maintaining healthy blood sugar levels already within the normal range. Direct human evidence at the dihydroberberine level remains limited; its role here is to deliver berberine more effectively, with the active end-form remaining berberine in tissue.

The formula also features CraveLock™ Technology, a proprietary synergistic approach to appetite management and Food Noise.

WONDERBIOTICS uses PolarSeal Technology to help protect the probiotic blend. In testing, 99.9% of the bacterial strain survived gut-like acidic conditions, and 98.2% of the bacteria remained alive through to the point of consumption.

The core ingredients in the formula are backed by 624 clinical studies covering 44,692 participants. The formula was developed by PhD scientists and industry experts.

We recommend taking it consistently for 3-6 months alongside a balanced diet and regular movement, to give your gut time to adapt and your body time to respond. The timeline reflects how the underlying biology actually works.

If you are in second puberty and considering this formula, treat it as an adjunct to the foundation (training, sleep, protein, clinical evaluation), not a substitute for it.

FAQ

Should I look for a probiotic specifically marketed to perimenopausal women?

Marketing positioning and trial evidence are different things. A label that says "for menopause" without citing a menopause-specific RCT is using positioning rather than evidence. Look at the named strains, check whether those strains have human RCT data on body composition endpoints, and read the trial population descriptions in the cited papers.

Is hormone therapy (HRT) better than supplements for this?

The two are different categories of intervention with different evidence bases, side-effect profiles, and indications. Menopausal hormone therapy is a clinical decision that depends on your symptoms, age, time since the final menstrual period, personal and family history, and overall risk profile. It is a conversation with your clinician, not a supplement comparison.

What if I have not officially entered perimenopause but feel like I am in second puberty already?

Symptoms can begin years before any formal diagnosis, and cycle changes may not be obvious early on. A clinician can evaluate hormone levels, thyroid function, and other factors that might explain or contribute to what you are experiencing. The evaluation itself is more important than the label.

The Foundation Comes First

Second puberty is real, the body composition shifts are documented, and the most evidence-backed interventions are not supplements. Resistance training, aerobic exercise, sleep, protein adequacy, and clinical evaluation form the foundation. A targeted probiotic with strain-level data on body composition endpoints can sit on top of that foundation as an adjunct, with honest framing about the evidence gap on menopause-specific outcomes.

A weight-management probiotic that names a strain like B420™, points to the published mixed-sex adult RCT, protects live cultures with testable delivery technology, and does not overclaim menopause specificity meets that adjunct standard. WONDERBIOTICS Probiotics for Weight Management is one such option, used alongside the foundation rather than in place of it.

This article is for educational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Perimenopause and menopause are life stages where clinical evaluation can identify treatable contributors and where decisions about hormone therapy, thyroid management, and other interventions belong with a qualified clinician. If you have symptoms or are considering supplements alongside other treatments, talk with a licensed clinician before making changes.

References

1. Greendale GA, Sternfeld B, Huang M, et al. Changes in body composition and weight during the menopause transition. JCI Insight. 2019;4(5):e124865. <https://insight.jci.org/articles/view/124865>
2. Hill C, Guarner F, Reid G, et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 2014;11(8):506-514. <https://www.nature.com/articles/nrgastro.2014.66>
3. Khalafi M, Habibi Maleki A, Sakhaei MH, et al. The effects of exercise training on body composition in postmenopausal women: a systematic review and meta-analysis. Front Endocrinol. 2023;14:1183765. <https://www.frontiersin.org/articles/10.3389/fendo.2023.1183765/full>
4. Stenman LK, Lehtinen MJ, Meland N, et al. Probiotic with or without fiber controls body fat mass, associated with serum zonulin, in overweight and obese adults: randomized controlled trial. EBioMedicine. 2016;13:190-200. <https://www.sciencedirect.com/science/article/pii/S2352396416304972>
5. Ribeiro CB, Ramos FM, Manthey JA, Cesar TB. Effectiveness of Eriomin® in managing hyperglycemia and reversal of prediabetes condition: A double-blind, randomized, controlled study. Phytother Res. 2019;33(7):1921-1933. <https://onlinelibrary.wiley.com/doi/10.1002/ptr.6386>